why choose us

Clinical Trials Search

Showing 5,400 of 132,656 result(s)
Clinical Efficacy of Mouthrinses Based on Chlorhexidine 0.12% and CITROX®

Status: COMPLETED

Condition: Periodontitis

Interventions: Patients use the undiluted mouthwash 2 times a day for 14 days after performing normal brushing.

Date: 2024-03-14

Motor Imagery and Isometric Exercises on Pelvic Floor Sensorimotor Condition

Status: COMPLETED

Condition: Isometric Exercise

Interventions: Isometric exercises (20 minutes) to which will be added a motor imagery intervention (imagining movements without actually doing them).

Date: 2024-03-14

Effect of Superficial Neuromuscular Stimulation in Post-stroke Dysphagic Patients.

Status: COMPLETED

Condition: Dysphagia

Interventions: With this application, swallowing muscles are stimulated and muscle strength increases.

Date: 2024-03-14

Longitudinal Outcomes in MED-EL Cochlear Implant Recipients Using a FLEX Electrode

Status: COMPLETED

Condition: Cochlear Implants

Interventions:

Date: 2024-03-13

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia;Schizoaffective Disorder

Status: COMPLETED

Condition: Schizophrenia, Schizoaffective Disorder

Interventions: Powder and vehicle for injectable suspension

Date: 2024-03-13

Virtual Reality to Promote Relaxation Prior to Simulation

Status: COMPLETED

Condition: Cancer

Interventions: Study participants will be provided a HTC or Pico VR head-mounted device (HTC Flow, HTC Focus or Pico Neo Pro) which will be fitted for comfort.

Date: 2024-03-13

Daily Vinegar Ingestion and 24-Hour Blood Glucose Control

Status: COMPLETED

Condition: Glucose Intolerance

Interventions: 3.5 g acetic acid

Date: 2024-03-13

Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001

Status: COMPLETED

Condition: Peanut Allergy

Interventions: IGNX001 given as a single subcutaneous dose on Day 1.

Date: 2024-03-12

Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke

Status: COMPLETED

Condition: Ischemic Stroke, Acute

Interventions:

Day 1(within 6.0 hours of onset, before or after intravenous thrombolysis) : Ticagrelor (180mg) + Aspirin (100mg), one dose;

Days 2-7: Ticagr

Date: 2024-03-12

Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD

Status: COMPLETED

Condition: Atopic Dermatitis

Interventions: Tablets

Date: 2024-03-12